Amyloid PET scan diagnosis of Alzheimer’s disease in patients with multiple sclerosis: a scoping review study

Amyloid PET scan diagnosis of Alzheimer’s disease in patients with multiple sclerosis: a scoping review study

Highlights The years after the first diagnosis and progressive or non-progressive MS are crucial factors in increasing the risk of early AD. The florbetapir-based radio traces in helping to diagnose early AD. Logical to use an age-specific cutoff in MS patients for early AD diagnosis.

Bibliographic Details
Main Authors: Mohammad Khalafi, Amirmohammad Rezaei Rashnoudi, Farzaneh Rahmani, Pouya Javanmardi, Pegah Panahi, Hassan Kiani Shahvandi, Mohammadhassan Tajik, Hussein Soleimantabar, Kiarash Shirbandi
Format: Article
Language:English
Published: SpringerOpen 2023-01-01
Series:The Egyptian Journal of Radiology and Nuclear Medicine
Subjects:
Neurodegenerative disease
Neuroinflammation
Neuroimaging
Dementia
Alzheimer's disease
Multiple sclerosis
Online Access:https://doi.org/10.1186/s43055-023-00964-8

Internet

https://doi.org/10.1186/s43055-023-00964-8

Similar Items